Journal of Cardiovascular Imaging
- Volume 16 Issue 4
- /
- Pages.130-132
- /
- 2008
- /
- 2586-7210(pISSN)
- /
- 2586-7296(eISSN)
Drug-Induced Dilated Cardiomyopathy Associated with Anagrelide
- Kim, Seong-Yoon (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
- Kim, Jang-Young (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
- Youn, Young-Jin (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
- Lee, Nam-Seok (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
- Ahn, Min-Soo (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
- Lee, Kyung-Hoon (Division of Cardiology, Wonju College of Medicine, Yonsei University) ;
- Kim, Ho-Young (Division of Hemato-Oncology, College of Medicine, Hallym University) ;
- Choe, Kyung-Hoon (Division of Cardiology, Wonju College of Medicine, Yonsei University)
- Published : 2008.12.27
Abstract
Anagrelide is an effective drug for essential thrombocythaemia, and its adverse cardiovascular effects are relatively rarely reported. We experienced a 73 year-old man with essential thrombocythaemia developed anagrelide-induced dilated cardiomyopathy. After discontinuation of anagrelide, the patient's left ventricular systolic function was completely recovered.